In cancer cells, three main mechanisms account for inactivation of the Rb pathway: genetic inactivation, sequestration by viral oncoproteins (such as T antigen, E1A or E7) or hyperphosphorylation as a consequence of perturbations of cdk activities. This evidence concerns the gene RB1 and cancer.